Results 61 to 70 of about 56,675 (275)

Common Structures of Asset-Backed Securities and Their Risks [PDF]

open access: yes
In recent years, one area of growing concern in corporate governance is the accounting and transfer of risk using special purpose entities (or trusts). Such entities are used widely in issuing asset-backed securities.
Tarun Sabarwal
core  

Alkaline Phosphatase‐Activated NIR‐II AIEgens Nanosystem for Surgical and Postoperative Closed‐Loop Therapy of Advanced Osteosarcoma

open access: yesAdvanced Science, EarlyView.
This study designed a tumor microenvironment‐responsive AIEgen nanoparticle for near‐infrared photoimmunotherapy, which inhibits primary tumors and metastasis by promoting pyroptosis and suppressing aerobic glycolysis. ABSTRACT In advanced osteosarcoma, tumor invasion often prevents complete resection, and immunotherapy is limited by the tumor's ...
Kaiyuan Liu   +14 more
wiley   +1 more source

Reversal of the Pension Reform in Poland

open access: yesSocialiniai Tyrimai, 2016
In the past, the Polish pension system was based on a pay-as-you-go rule. On 1 January 1999 Poland introduced a major pension reform in order to improve sustainability of the pension system. The new system consisted of three independent pillars.
Sebastian Jakubowski
doaj   +1 more source

TALF: Jump-starting the securitization markets [PDF]

open access: yes
In the financial crisis that began in August 2007, securitization activity virtually dried up. When the housing bubble burst, the value of the collateral backing much of the asset-backed securities (ABS) declined sharply, and so did the value of the ...
Kenneth J. Robinson
core  

Iron Oxide Nanozyme as Reactive Oxygen and Nitrogen Species Scavenger to Regulate Microglial Homeostasis in Stroke

open access: yesAdvanced Science, EarlyView.
6 nm iron oxide nanoparticles (IONP6) exhibit enzyme‐like activities that scavenge reactive oxygen and nitrogen species (RONS), including nitric oxide (NO). In stroke models, IONP6 promotes microglial polarization toward the M2 phenotype, reduces neuroinflammation, and improves neurological outcomes, offering a promising drug‐free approach to mitigate ...
Yilin Qi   +12 more
wiley   +1 more source

LITIGATIONS, DAMAGES AND SOLUTIONS IN RESIDENTIAL MORTGAGE-BACKED SECURITIES [PDF]

open access: yes
Mortgage-backed securities (MBS) are debt obligations whose cash flows are backed by the principal and interest payments of pools of mortgage loans, most commonly on residential property (Riddiough, 2001).
Jomadar, Dinesh
core   +1 more source

Shared scepticism, different motives: Franco-German perceptions of a common European safe asset. Bertelsmann Stiftung 26 October 2018 [PDF]

open access: yes, 2018
A common European safe asset is a highly contentious proposal within the Euro area reform agenda. Various safe asset proposals have been put forward since the onset of the Euro crisis ranging from Eurobonds to European Safe Bonds (ESBies), also known as ...
Best, Kris
core  

Generating Dynamic Structures Through Physics‐Based Sampling of Predicted Inter‐Residue Geometries

open access: yesAdvanced Science, EarlyView.
While static structure prediction has been revolutionized, modeling protein dynamics remains elusive. trRosettaX2‐Dynamics is presented to address this challenge. This framework leverages a Transformer‐based network to predict inter‐residue geometric constraints, guiding conformation generation via physics‐based iterative sampling. The resulting method
Chenxiao Xiang   +3 more
wiley   +1 more source

Diversification first: Why the euro area does not need an artificial safe asset. CEPS Commentary, 25 May 2018 [PDF]

open access: yes, 2018
The European Commission has now tabled ‘enabling’ legislation for the creation of ‘SBBS’, sovereign bond-backed securities. The official purpose is to allow financial markets to create a ‘safe asset’, which should be used by banks instead of government ...
Gros, Daniel.
core  

A NeuroD1 AAV‐Based Gene Therapy for Functional Brain Repair in Alzheimer's Disease‐Like Non‐Human Primate Model

open access: yesAdvanced Science, EarlyView.
This study tests NeuroD1 AAV‐based gene therapy in a non‐human primate Alzheimer's disease model. The therapy prevents neuronal damage, inhibits hippocampal atrophy, and reduces neuroinflammation. It also repairs vascular and blood‐brain barrier damage, restores cerebrospinal fluid biomarkers, enhances hippocampal glucose metabolism, and improves ...
Zhouquan Jiang   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy